Kim SE - Search Results

1

Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.

Lee JJ, Shetty D, Lee YS, Kim SE, Kim YJ, Hong MK, Son JY, Jeong JM. Lee JJ, et al. Among authors: kim yj, kim se. Nucl Med Biol. 2012 Apr;39(3):325-33. doi: 10.1016/j.nucmedbio.2011.09.010. Epub 2011 Dec 1. Nucl Med Biol. 2012. PMID: 22136890

2

Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.

Kim SE, Choi JY, Choe YS, Choi Y, Lee WY. Kim SE, et al. J Nucl Med. 2003 Jun;44(6):870-6. J Nucl Med. 2003. PMID: 12791812 Free article. Clinical Trial.

3

Synthesis and evaluation of 5,7-dihydro-3-[2-[1-(4-[18F]-fluorobenzyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one for in vivo mapping of acetylcholinesterase.

Lee SY, Choe YS, Kim YR, Paik JY, Choi BW, Kim SE, Lee KH, Choi Y, Kim BT. Lee SY, et al. Among authors: kim se, kim bt, kim yr. Nucl Med Commun. 2004 Jun;25(6):591-6. doi: 10.1097/01.mnm.0000126629.09543.1d. Nucl Med Commun. 2004. PMID: 15167519

4

Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase.

Ryu EK, Choe YS, Park EY, Paik JY, Kim YR, Lee KH, Choi Y, Kim SE, Kim BT. Ryu EK, et al. Among authors: kim se, kim bt, kim yr. Nucl Med Biol. 2005 Feb;32(2):185-91. doi: 10.1016/j.nucmedbio.2004.09.006. Nucl Med Biol. 2005. PMID: 15721764

5

Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.

Shim HK, Lee WW, Park SY, Kim H, So Y, Kim SE. Shim HK, et al. Among authors: kim h, kim se. Nucl Med Biol. 2009 Feb;36(2):191-7. doi: 10.1016/j.nucmedbio.2008.11.009. Nucl Med Biol. 2009. PMID: 19217531

6

Aromatic radiofluorination and biological evaluation of 2-aryl-6-[18F]fluorobenzothiazoles as a potential positron emission tomography imaging probe for β-amyloid plaques.

Lee BC, Kim JS, Kim BS, Son JY, Hong SK, Park HS, Moon BS, Jung JH, Jeong JM, Kim SE. Lee BC, et al. Among authors: kim bs, kim se, kim js. Bioorg Med Chem. 2011 May 1;19(9):2980-90. doi: 10.1016/j.bmc.2011.03.029. Epub 2011 Mar 21. Bioorg Med Chem. 2011. PMID: 21478020

7

Bronchial anthracofibrosis: a potential false-positive finding on F-18 FDG PET.

Choi HY, Kim YK, Lee JJ, Kim SE. Choi HY, et al. Among authors: kim yk, kim se. Ann Nucl Med. 2012 Oct;26(8):681-3. doi: 10.1007/s12149-012-0611-6. Epub 2012 Jun 8. Ann Nucl Med. 2012. PMID: 22678623

8

Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.

Moon BS, Jang SJ, Kim SJ, Lee TS, Chi DY, Lee BC, Kang JH, Kim SE. Moon BS, et al. Among authors: kim se, kim sj. Cancer Biother Radiopharm. 2013 Oct;28(8):588-97. doi: 10.1089/cbr.2012.1408. Epub 2013 May 19. Cancer Biother Radiopharm. 2013. PMID: 23682585 Free PMC article.

9

Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.

Lee Y, Chung JH, Kim SE, Kim TJ, Lee KW. Lee Y, et al. Among authors: kim se, kim tj. Clin Nucl Med. 2014 Feb;39(2):107-12. doi: 10.1097/RLU.0b013e3182952c2d. Clin Nucl Med. 2014. PMID: 23751831

10

Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.

Im HJ, Kim YK, Kim YI, Lee JJ, Lee WW, Kim SE. Im HJ, et al. Among authors: kim yi, kim yk, kim se. Nucl Med Mol Imaging. 2013 Mar;47(1):36-43. doi: 10.1007/s13139-012-0181-5. Epub 2012 Nov 17. Nucl Med Mol Imaging. 2013. PMID: 24895506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,530 results

Search Page

Filters